|
1
|
Gitt AK, Lautsch D, Lautsch D, Horack M, Horack M, Baxter CA, Baxter CA, De Ferrari G, De Ferrari G, Ferrieres J, Ferrieres J. P5383Risk for major adverse cardiovascular events estimated by the TIMI Risk Score for Secondary Prevention TRS2P in patients with coronary artery disease did not impact lipid lowering treatment in clinica. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- A K Gitt
- Herzzentrum Ludwigshafen, Cardiology and Stiftung Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany
| | | | | | - M Horack
- Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany
| | - M Horack
- Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany
| | - C A Baxter
- Merck & Co., Inc., Kenilworth, United States of America
| | - C A Baxter
- Merck & Co., Inc., Kenilworth, United States of America
| | | | | | - J Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | - J Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | | |
Collapse
|
|
2
|
Gitt AK, Lautsch D, Horack M, Baxter CA, Ferrieres J, De Ferrari G. P781Better LDL-cholesterol-target attainment in patients with ACS and type 2 diabetes - results of DYSIS II ACS. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A K Gitt
- Herzzentrum Ludwigshafen, Cardiology and Stiftung Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany
| | | | - M Horack
- Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany
| | - C A Baxter
- Merck & Co., Inc., Kenilworth, United States of America
| | - J Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | | | | |
Collapse
|
|
3
|
Gitt A, Lautsch D, Horack M, Brudi P, Poh K, De Ferrari G, Ferrieres J. P629Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South Africa, Middle East and China: results of the Dyslipidemia International Study (DYSIS). Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A.K. Gitt
- Herzzentrum Ludwigshafen, Cardiology and Stiftung Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany
| | | | - M. Horack
- Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany
| | - P.H. Brudi
- Merck & Co, Inc., Kenilworth, United States of America
| | - K.K. Poh
- National University of Singapore, Singapore, Singapore
| | | | - J. Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | | |
Collapse
|
|
4
|
Gitt A, Lautsch D, Horack M, Brudi P, Poh K, De Ferrari G, Ferrieres J. P173Low LDL-cholesterol goal attainment 4 months after ACS due to lack of adjustment in lipid lowering treatment: Results from DYSIS II. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- A.K. Gitt
- Herzzentrum Ludwigshafen, Cardiology and Stiftung Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany
| | | | - M. Horack
- Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany
| | - P.H. Brudi
- Merck & Co, Inc., Kenilworth, United States of America
| | - K.K. Poh
- National University of Singapore, Singapore, Singapore
| | | | - J. Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | | |
Collapse
|